On the campaign trail, both former President Donald Trump and Vice President Kamala Harris are eager to portray themselves as guardians of Medicare. Each presidential candidate accuses the other of backing spending cuts and other policies that would damage the health insurance program for older Americans. But the election’s outcome could alter the very nature…
The healthcare investor conference MedCity INVEST, scheduled for May 20-21 at the Willis Tower in Chicago, will spotlight a wide range of topics from GLP-1 drug coverage to investment trends and more. Register today! The post What Are Health Systems’ Strategic Priorities in 2025? appeared first on MedCity News.
Even the most promising medical advancements struggle to take off in real-world settings without clinician buy-in. Here are some key factors that affect clinician adoption and ways healthtech companies can better position their innovations for success. The post Clinician Adoption: How HealthTech Can Overcome Key Barriers appeared first on MedCity News.
Improved automation and data-driven solutions are optimizing the patient collections process, even as providers face rising costs, shrinking reimbursements, looming changes to credit reporting, and an ongoing push toward greater efficiency. How do current solutions stack up against these challenges? Matt Hanas, Lead Product Manager at Experian Health, shares responses to some of the questions…
Despite increased access to claims management technology, claims denials are still on the rise in 2024. Contributing factors include growing healthcare costs, stricter payer reimbursement policies, and claims processing errors. Providers are seeing an uptick in nonpayment, plus an added burden on administrative staff, disrupted patient care, and hits to the bottom line. Experian Health…
The Republican-led Congress is considering plans to cut Medicaid to help pay for tax cuts, with the House budget resolution targeting $880 billion or more in potential reductions to federal Medicaid spending. To better understand the experiences of Medicaid enrollees and their perceptions of potential changes to the program, KFF conducted five virtual focus groups…
How race, ethnicity, and nationality have been defined and measured has important implications for health disparities, affecting who can access health, social, and economic resources. While narrow and inconsistent race and ethnicity categories have obscured inequities and limited the ability to address the diverse needs of different populations, data on race and ethnicity have also…
Personify Health Chief Medical Officer Jeff Jacques offers a window into companies’ strategies for including GLP-1 drugs in their health benefits. The post MedCity Pivot Podcast: Self-insured Employers Weigh Benefits of GLP-1 Drugs appeared first on MedCity News.
Tariffs on pharmaceuticals. First, President Trump has voiced his goal to impose tariffs on pharmaceutical products made overseas. The New York Times reports: Mr. Trump said in remarks to reporters on Monday that pharmaceutical tariffs would come in the “not too distant future.”“We don’t make our own drugs anymore,” Mr. Trump said. “The drug companies…
If we gut school-based care, we’re not only closing doors, we’re also deepening the racial and economic inequities that already shape our mental health system. We can’t claim to care about equity in healthcare if we’re willing to strip care from the very places that reach the kids who need it most. The post The…